Trial intelligence / Profile preview

ReDCard trial of remimazolam versus conventional anesthesia in cardiac surgery

jRCT1051210195Completed

Start
Mar 2022
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of remimazolam, propofol and desflurane in cardiac disease (2 arms). Primary endpoint: Incidence of postoperative delirium. Started Mar 2022; status: completed.

02

Drugs

remimazolampropofoldesflurane
03

Conditions

cardiac disease

Beyond the preview

Go deeper on jRCT1051210195.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1051210195.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call